• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大动脉炎患者非血管肺部表现的患病率:一项回顾性多中心土耳其队列研究。

The prevalence of non-vascular pulmonary manifestations in Takayasu's Arteritis patients: A Retrospective multi-centred Turkish cohort study.

机构信息

Department of Internal Medicine, Division of Rheumatology, School of Medicine, Kocaeli University, Kocaeli, Turkey.

Department of Internal Medicine, Division of Rheumatology, School of Medicine, Marmara University, Istanbul, Turkey.

出版信息

Scand J Rheumatol. 2022 Jul;51(4):304-308. doi: 10.1080/03009742.2021.1972535. Epub 2021 Oct 13.

DOI:10.1080/03009742.2021.1972535
PMID:34643164
Abstract

OBJECTIVES

Takayasu's arteritis (TAK) is a rare vasculitis characterized by inflammation of intermediate- to large-size arteries. Although pulmonary artery involvement (PAI) is an expected finding in some TAK patients, data on non-vascular pulmonary involvement (NVPI) are limited. We aimed to investigate the frequency of NVPI, including parenchymal infiltration, nodules/cavities, pleural effusion, and haemorrhage, in TAK.

METHOD

We assembled a retrospective cohort of TAK patients from nine tertiary centres in Turkey. The demographics and clinical characteristics of patients were extracted from medical records and the imaging findings were evaluated for pulmonary manifestations.

RESULTS

As of January 2021, 319 TAK patients (female/male 276/43; mean age 42.4 ± 13.5 years) were recruited. Eighty-two patients had cough and/or dyspnoea and four had haemoptysis as pulmonary symptoms. On computed tomography assessment, the overall frequency of NVPI was 7.2%; parenchymal infiltrations were present in 10 (3.1%), pleural effusion in eight (2.5%), nodules/cavities in six (1.9%), and pulmonary haemorrhage in four patients (1.3%). In the whole cohort, 10.3% of patients had pulmonary artery hypertension (PAH) and 5.6% had PAI. Among patients with PAH or PAI, the overall frequency of NVPI was significantly higher than in the rest of the group.

CONCLUSIONS

In this TAK cohort from Turkey, we observed NVPI in 7.2% of patients, with parenchymal infiltrations being the most common, followed by pleural effusion. Notably, NVPI was more frequent in patients with PAH or PAI. Although not as common as PAI, NVPI should be kept in mind, especially in TAK patients with PAH or PAI.

摘要

目的

Takayasu 动脉炎(TAK)是一种罕见的血管炎,其特征为中等至大血管的炎症。虽然肺动脉受累(PAI)在一些 TAK 患者中是预期的发现,但关于非血管性肺受累(NVPI)的数据有限。我们旨在研究 TAK 中 NVPI 的频率,包括实质浸润、结节/空洞、胸腔积液和出血。

方法

我们从土耳其的 9 个三级中心组建了一个 TAK 患者的回顾性队列。从病历中提取患者的人口统计学和临床特征,并评估影像学表现以评估肺部表现。

结果

截至 2021 年 1 月,共纳入 319 名 TAK 患者(女/男 276/43;平均年龄 42.4±13.5 岁)。82 名患者有咳嗽和/或呼吸困难,4 名患者有咯血等肺部症状。在计算机断层扫描评估中,NVPI 的总体发生率为 7.2%;实质浸润 10 例(3.1%),胸腔积液 8 例(2.5%),结节/空洞 6 例(1.9%),肺出血 4 例(1.3%)。在整个队列中,10.3%的患者有肺动脉高压(PAH),5.6%有 PAI。在有 PAH 或 PAI 的患者中,NVPI 的总体发生率明显高于其他组。

结论

在土耳其的这个 TAK 队列中,我们观察到 7.2%的患者有 NVPI,最常见的是实质浸润,其次是胸腔积液。值得注意的是,PAH 或 PAI 患者的 NVPI 更为常见。尽管不如 PAI 常见,但应注意到 NVPI,尤其是在有 PAH 或 PAI 的 TAK 患者中。

相似文献

1
The prevalence of non-vascular pulmonary manifestations in Takayasu's Arteritis patients: A Retrospective multi-centred Turkish cohort study.大动脉炎患者非血管肺部表现的患病率:一项回顾性多中心土耳其队列研究。
Scand J Rheumatol. 2022 Jul;51(4):304-308. doi: 10.1080/03009742.2021.1972535. Epub 2021 Oct 13.
2
Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis.大动脉炎患者心血管危险因素发生频率的评估。
Rheumatology (Oxford). 2017 Nov 1;56(11):1939-1944. doi: 10.1093/rheumatology/kex300.
3
The clinical features of pulmonary artery involvement in Takayasu arteritis and its relationship with ischemic heart diseases and infection.Takayasu 动脉炎肺动脉受累的临床特征及其与缺血性心脏病和感染的关系。
Arthritis Res Ther. 2021 Dec 3;23(1):293. doi: 10.1186/s13075-021-02675-9.
4
[The analysis of the clinical records diagnosed as Takayasu's arteritis with pulmonary vascular involvement].[对诊断为合并肺血管受累的高安动脉炎的临床记录进行分析]
Zhonghua Jie He He Hu Xi Za Zhi. 2016 Aug;39(8):603-7. doi: 10.3760/cma.j.issn.1001-0939.2016.08.011.
5
Cardiopulmonary involvement in Takayasu's arteritis.大动脉炎的心肺受累。
Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):46-50. Epub 2017 Jun 12.
6
Predictors for pulmonary artery involvement in Takayasu arteritis and its cluster analysis.大动脉炎肺动脉受累的预测因素及其聚类分析。
Arthritis Res Ther. 2023 Jan 14;25(1):9. doi: 10.1186/s13075-022-02987-4.
7
Risk assessment model for heart failure in Chinese patients with Takayasu's arteritis.中国 Takayasu 动脉炎患者心力衰竭风险评估模型。
Clin Rheumatol. 2021 Oct;40(10):4117-4126. doi: 10.1007/s10067-021-05745-0. Epub 2021 May 22.
8
Clinical symptoms and associated vascular imaging findings in Takayasu's arteritis compared to giant cell arteritis.与巨细胞动脉炎相比,Takayasu 动脉炎的临床症状及相关血管影像学表现。
Ann Rheum Dis. 2020 Feb;79(2):262-267. doi: 10.1136/annrheumdis-2019-216145. Epub 2019 Oct 24.
9
Coronary artery calcification in Takayasu's arteritis: clinical characteristics and risk factors.Takayasu 动脉炎患者的冠状动脉钙化:临床特征和危险因素。
Clin Exp Rheumatol. 2024 Apr;42(4):843-851. doi: 10.55563/clinexprheumatol/ypq2lj. Epub 2024 Apr 11.
10
Long-term outcomes and prognostic predictors of patients with Takayasu's arteritis along with pulmonary artery involvement.伴肺动脉受累的 Takayasu 动脉炎患者的长期预后及其预测因素。
Clin Exp Rheumatol. 2022 May;40(4):765-771. doi: 10.55563/clinexprheumatol/mbs830. Epub 2022 Jan 27.